The global anti-hiv drugs market is witnessing steady growth as healthcare systems continue to expand access to antiretroviral therapy, improve HIV diagnosis and treatment programs, and strengthen long-term disease management. Anti-HIV drugs include multiple classes of antiretroviral medicines used in combination therapies to suppress HIV replication, maintain immune function, and reduce the...
The global Molecular Diagnostics Market is projected to grow from USD 19.4 billion in 2026 to USD 25.6 billion by 2033, registering a 4.1% CAGR. The market reached USD 18.8 billion in 2025, with North America accounting for the largest regional share at 44.1%.
The industry's growth reflects increasing demand for precise diagnostics, technological advancement,...
The global Molecular Diagnostics Market size was valued at USD 18.8 billion in 2025 and is projected to grow from USD 19.4 billion in 2026 to USD 25.6 billion by 2033, registering a CAGR of 4.1% from 2026 to 2033. North America dominated the market with a 44.1% revenue share in 2025. The growth of the molecular diagnostics industry is driven by increasing...
Infectious Disease Testing Market
The Infectious Disease Testing Market is experiencing strong expansion driven by the rising global burden of infectious diseases, increasing demand for early diagnosis, and advancements in molecular diagnostic technologies. The market size was valued at USD 28 billion in 2025 and is projected to grow from USD 30 billion in 2026 to USD...
The global infectious disease testing market is experiencing significant growth due to the increasing prevalence of infectious diseases, rising awareness regarding early disease diagnosis, and growing adoption of advanced diagnostic technologies. Infectious disease testing plays a critical role in detecting bacterial, viral, fungal, and parasitic infections, enabling timely treatment...
The global syphilis testing market size was estimated at USD 1.57 billion in 2025 and is projected to reach USD 2.32 billion by 2033, growing at a CAGR of 5.23% from 2026 to 2033. The market is witnessing sustained growth due to the rising prevalence of syphilis infections, increasing congenital syphilis cases, expanding public health screening initiatives, and growing adoption of...
The Anti-Infective Drugs Market continues to play a foundational role in global healthcare systems, addressing a broad spectrum of bacterial, viral, fungal, and parasitic infections. Valued at US$ 134,267.21 Million in 2024, the market is projected to expand at a CAGR of 3.1% from 2025 to 2032. Despite moderate growth, sustained demand is supported by rising infectious disease prevalence,...
[Hyderabad, 21 June 2025] – The North America Infectious Disease Therapeutics Market is set to experience robust growth over the next decade, projected to rise from USD 38.2 billion in 2024 to USD 67.5 billion by 2032, expanding at a CAGR of 7.1%. This growth trajectory is propelled by increasing infectious disease prevalence, rapid advancements in therapeutics, and strategic investment...
[Hyderabad, 21 June 2025] – The North America Infectious Disease Therapeutics Market is set to experience robust growth over the next decade, projected to rise from USD 38.2 billion in 2024 to USD 67.5 billion by 2032, expanding at a CAGR of 7.1%. This growth trajectory is propelled by increasing infectious disease prevalence, rapid advancements in therapeutics, and strategic investment...
Latin America Infectious Disease Therapeutics Market to Reach USD 18.7 Billion by 2032 Amid Rising Disease Burden and Advancements in Drug Development
[Hyderabad, 21 June 2025] - The Latin America Infectious Disease Therapeutics Market is poised for substantial growth, projected to increase from USD 10.2 billion in 2024 to USD 18.7 billion by 2032, registering a CAGR of 7.8% during the...
[Hyderabad, 21 June 2025] – According to a recent industry report, the Europe Infectious Disease Therapeutics Market is projected to grow significantly, reaching USD 51.2 billion by 2032, up from USD 28.4 billion in 2024, expanding at a robust CAGR of 7.6% during the forecast period (2024–2032). This growth is underpinned by an increasing prevalence of infectious diseases, rising...
[Hyderabad, 21 June 2025] – According to a recent industry report, the Europe Infectious Disease Therapeutics Market is projected to grow significantly, reaching USD 51.2 billion by 2032, up from USD 28.4 billion in 2024, expanding at a robust CAGR of 7.6% during the forecast period (2024–2032). This growth is underpinned by an increasing prevalence of infectious diseases, rising...